Clinical trial
Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients
NCT02538172 is registered in ClinicalTrials.gov with University of Lausanne Hospitals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients
- Lead sponsor
- University of Lausanne Hospitals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- January 31, 2021
- Enrollment
- 195 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.